Literature DB >> 2605345

Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.

L Pedersen1, S Holck, T Schiødt, K Zedeler, H T Mouridsen.   

Abstract

One hundred thirty-one breast carcinomas with medullary features, registered in the Danish Breast Cancer Cooperative Group from 1977-1982, have been histopathologically reviewed by two senior pathologists and classified as typical medullary carcinoma (TMC), atypical medullary carcinoma (AMC), and non-medullary carcinoma (NMC). Diagnostic criteria were based on those put forward by Ridolfi et al. and Fisher et al. The procedure was repeated with an interval of about one year by both pathologists. The diagnostic interobserver agreement was 72% with a Kappa of 0.55. The intraobserver agreement was 77% and 63% with Kappa values of 0.64 and 0.44, respectively. To see whether the observed inter- and intraobserver variability had any prognostic implications, diagnostic subgroups for both pathologists were analyzed with Kaplan Meier plots for recurrence-free survival (RFS) and with log rank tests. In the first evaluation pathologist 1 segregated a group of TMC with a significantly better RFS than for the NMC group, and pathologist 2 segregated a group of TMC with a corresponding strong trend. These findings could not, however, be reproduced in the second evaluation. The study indicates that the criteria of TMC and AMC as proposed by Ridolfi et al. need to be sharpened and simplified in order to reduce inter- and intraobserver variability. Larger studies with a control group of infiltrating ductal carcinomas are mandatory to elucidate the clinical importance of the diagnoses of Typical and Atypical Medullary Carcinoma of the breast.

Entities:  

Mesh:

Year:  1989        PMID: 2605345     DOI: 10.1007/bf01805979

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  Improved prognosis in certain patterns of carcinoma of the breast. Colloid, medullary with lymphoid stroma, and intraductal.

Authors:  J H WULSIN; J T SCHREIBER
Journal:  Arch Surg       Date:  1962-11

2.  Medullary carcinoma of the breast. Type I and type 3 tumours.

Authors:  F Hartveit
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-03

3.  [The kappa coefficient--a goal for evaluating the reproducibility of nominal and ordinary data].

Authors:  T Gjørup; A M Jensen
Journal:  Nord Med       Date:  1986

4.  The significance of lymph node involvement in patients with medullary carcinoma of the breast.

Authors:  C L Black; D M Morris; L I Goldman; J C McDonald
Journal:  Surg Gynecol Obstet       Date:  1983-12

5.  Organisation of the Danish adjuvant trials in breast cancer.

Authors:  K W Andersen; H T Mouridsen; T Castberg; K Fischerman; J Andersen; K Hou-Jensen; H Brincker; H Johansen; E Henriksen; M Rørth; N Rossing
Journal:  Dan Med Bull       Date:  1981-08

6.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

7.  Observer variability in reporting of breast lesions.

Authors:  J S Beck
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

8.  The pathological classification of human mammary carcinoma: past, present and future.

Authors:  P P Rosen
Journal:  Ann Clin Lab Sci       Date:  1979 Mar-Apr       Impact factor: 1.256

9.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

10.  Histopathological systems of breast cancer classification: reproducibility and clinical significance.

Authors:  B Stenkvist; E Bengtsson; O Eriksson; T Jarkrans; B Nordin; S Westman-Naeser
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

View more
  12 in total

1.  Impact of a national external quality assessment scheme for breast pathology in the UK.

Authors:  I O Ellis; D Coleman; C Wells; S Kodikara; E M Paish; S Moss; S Al-Sam; N Anderson; L Bobrow; I Buley; C E Connolly; N S Dallimore; S Hales; A Hanby; S Humphreys; F Knox; J Lowe; J Macartney; R Nash; D Parham; J Patnick; S E Pinder; C M Quinn; A J Robertson; J Shrimankar; R A Walker; R Winder
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Breast cancer subtypes: morphologic and biologic characterization.

Authors:  Shahla Masood
Journal:  Womens Health (Lond)       Date:  2016-01-12

3.  Medullary carcinoma of the breast: a population-based perspective.

Authors:  Steve R Martinez; Shannon H Beal; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold
Journal:  Med Oncol       Date:  2011-09       Impact factor: 3.064

Review 4.  Medullary cancer of the breast revisited.

Authors:  E R Fisher; J P Kenny; R Sass; N V Dimitrov; R H Siderits; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

5.  [Diagnosis and immunohistochemistry of medullary breast cancer].

Authors:  S Milde; J Gaedcke; R v Wasielewski; H Bruchardt; L Wingen; D Gadzicki; H Arps; H H Kreipe
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

6.  Multifunctional Quantum Dots for Personalized Medicine.

Authors:  Pavel Zrazhevskiy; Xiaohu Gao
Journal:  Nano Today       Date:  2009-10-05       Impact factor: 20.722

7.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.

Authors:  Ming Lee; Ana Richelia Jara-Lazaro; Poh Yian Cheok; Aye Aye Thike
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

10.  Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Authors:  Bas Kreike; Marieke van Kouwenhove; Hugo Horlings; Britta Weigelt; Hans Peterse; Harry Bartelink; Marc J van de Vijver
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.